WAFF, January 31, 2020 – The Wuhan coronavirus is a global disease triggering a global response, and researchers at the HudsonAlpha Institute for Biotechnology are pulling their weight.
Sister companies iCubate and iRepertoire (under the HudsonAlpha umbrella) are developing and distributing technology which diagnoses and treats the illness.
iCubate has developed a program that allows human DNA to be tested for dozens of diseases at a time.
DNA is put in a “cassette” then plugged into a large cube-shaped scanner, which feeds results into the computer.
It will allow doctors to more quickly identify what’s wrong with the patient and how to best treat them.
iCubate CEO Carter Wells said the goal is to save lives and be faster about it.
“That [doctor] is able to say this is what we have, and this is the appropriate treatment, rather than just saying we’re going to hit them with the kitchen sink,” he said.